Synapse Open Synapse
Science

Rare GLP1R variants diminish the weight loss effect of semaglutide but not of tirzepatide | Nature Metabolism

Reddit · r/science ·

In a large, real-world genomic study, rare damaging variants in the gene encoding the glucagon-like peptide 1 (GLP1) receptor blunted weight loss in people taking semaglutide but had no significant effect on weight loss with tirzepatide, a drug that also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor.

Latest from Reddit · r/science